By LESLIE PICKER and CHAD BRAY
Shire, best known for A.D.H.D. drugs, and Baxalta, which sells a drug for hemophilia, could generate more than $20 billion in sales by 2020, Shire said.
Published: January 12, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1OX6FYb
from WordPress http://ift.tt/1RhUwNE
via Hadi Aboukhater
No comments:
Post a Comment